About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [2,220 citations: 1–100 of 1,947 articles]

Articles published in Parkinson’s Disease have been cited 2,220 times. The following is a list of the 1,947 articles that have cited the articles published in Parkinson’s Disease.

  • Nevenka Dudvarski Stankovic, Marcin Teodorczyk, Robert Ploen, Frauke Zipp, and Mirko H. H. Schmidt, “Microglia-blood vessel interactions: a double-edged sword in brain pathologies,” Acta Neuropathologica, vol. 131, no. 3, pp. 347–363, 2016. View at Publisher · View at Google Scholar
  • Terencio Daunte McGlasson, “Beyond the Tremors: What Counselors Should Know About the Mental Health Needs of Clients Diagnosed With Parkinson's Disease,” Adultspan Journal, vol. 15, no. 1, pp. 38–48, 2016. View at Publisher · View at Google Scholar
  • Satoshi Orimo, Makiko Yogo, Tomohiko Nakamura, Masahiko Suzuki, and Hirohisa Watanabe, “Brain imaging in Aging Special Issue of Ageing Research Reviews 123I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in α-synucleinopathies,” Ageing Research Reviews, 2016. View at Publisher · View at Google Scholar
  • Ahmet Yalcin, Volkan Atmis, Ozlem Karaarslan Cengiz, Esat Cinar, Sevgi Aras, Murat Varli, and Teslime Atli, “Evaluation of Cardiac Autonomic Functions in Older Parkinson’s Disease Patients: a Cross-Sectional Study,” Aging and Disease, vol. 7, no. 1, pp. 28, 2016. View at Publisher · View at Google Scholar
  • Matthew Redmann, Victor Darley-Usmar, and Jianhua Zhang, “The Role of Autophagy, Mitophagy and Lysosomal Functions in Modulating Bioenergetics and Survival in the Context of Redox and Proteotoxic Damage: Implications for Neurodegenerative Diseases,” Aging and Disease, vol. 7, no. 2, pp. 150, 2016. View at Publisher · View at Google Scholar
  • Heng Hu, Danielle N. Doll, Jiahong Sun, Sara E. Lewis, Jeffrey H. Wimsatt, Matthew J. Kessler, James W. Simpkins, and Xuefang Ren, “Mitochondrial Impairment in Cerebrovascular Endothelial Cells is Involved in the Correlation between Body Temperature and Stroke Severity,” Aging and Disease, vol. 7, no. 1, pp. 14, 2016. View at Publisher · View at Google Scholar
  • Pauline Narme, Martine Roussel, Harold Mouras, Pierre Krystkowiak, and Olivier Godefroy, “Does impaired socioemotional functioning account for behavioral dysexecutive disorders? Evidence from a transnosological study,” Aging, Neuropsychology, and Cognition, pp. 1–14, 2016. View at Publisher · View at Google Scholar
  • Susanna R. Var, Tyler R.C. Day, Andrej Vitomirov, Davey M. Smith, Virawudh Soontornniyomkij, David J. Moore, Cristian L. Achim, Sanjay R. Mehta, and Josué Pérez-Santiago, “Mitochondrial injury and cognitive function in HIV infection and methamphetamine use,” Aids, vol. 30, no. 6, pp. 839–848, 2016. View at Publisher · View at Google Scholar
  • Hui Zuo, Per M. Ueland, Arve Ulvik, Simone J. P. M. Eussen, Stein E. Vollset, Ottar Nygård, Øivind Midttun, Despoina Theofylaktopoulou, Klaus Meyer, and Grethe S. Tell, “Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality,” American Journal of Epidemiology, pp. kwv242, 2016. View at Publisher · View at Google Scholar
  • Florian Reinhart, Diane Agay, Napoleon Torres, Dhaif Bekha, Vincent Auboiroux, Thomas Costecalde, Cassandra L. Peoples, Helena D. T. Anastascio, Victoria E. Shaw, Jonathan Stone, John Mitrofanis, Alim-Louis Benabid, Fannie Darlot, Cecile Moro, Nabil El Massri, Claude Chabrol, and Daniel M. Johnstone, “Near-Infrared Light Is Neuroprotective in a Monkey Model of Parkinson Disease,” Annals Of Neurology, vol. 79, no. 1, pp. 59–75, 2016. View at Publisher · View at Google Scholar
  • Shuaipeng Ma, Xuefei Zhang, Liangjun Zheng, Zeyang Li, Xuyang Zhao, Wenjia Lai, Hongyan Shen, Junniao Lv, Guofeng Yang, Qingsong Wang, and Jianguo Ji, “Peroxiredoxin 6 Is a Crucial Factor in the Initial Step of Mitochondrial Clearance and Is Upstream of the PINK1-Parkin Pathway,” Antioxidants & Redox Signaling, vol. 24, no. 9, pp. 486–501, 2016. View at Publisher · View at Google Scholar
  • Meng Ni, Joseph F. Signorile, Kiersten Mooney, Anoop Balachandran, Melanie Potiaumpai, Corneliu Luca, James G. Moore, Christopher M. Kuenze, Moataz Eltoukhy, and Arlette C. Perry, “Comparative Effect of Power Training and High-Speed Yoga on Motor Function in Older Patients With Parkinson Disease,” Archives Of Physical Medicine And Rehabilitation, vol. 97, no. 3, pp. 345–354, 2016. View at Publisher · View at Google Scholar
  • Alice Estevo Dias, Maira Tonidandel Barbosa, Joao Carlos Papaterra Limongi, and Egberto Reis Barbosa, “Speech disorders did not correlate with age at onset of Parkinson's disease,” Arquivos De Neuro-Psiquiatria, vol. 74, no. 2, pp. 117–121, 2016. View at Publisher · View at Google Scholar
  • Filipe C. Matheus, Daniel Rial, Joana I. Real, Cristina Lemos, Juliana Ben, Gisele O. Guaita, Ines R. Pita, Ana C. Sequeira, Frederico C. Pereira, Roger Walz, Reinaldo N. Takahashi, Leandro J. Bertoglio, Claudio Da Cunha, Rodrigo A. Cunha, and Rui D. Prediger, “Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats,” Behavioural Brain Research, vol. 301, pp. 43–54, 2016. View at Publisher · View at Google Scholar
  • Katherine A. O'Connor, Paul J. Feustel, Adolfo Ramirez-Zamora, Eric Molho, Julie G. Pilitsis, and Damian S. Shin, “Investigation of diazepam efficacy on anxiety-like behavior in hemiparkinsonian rats,” Behavioural Brain Research, vol. 301, pp. 226–237, 2016. View at Publisher · View at Google Scholar
  • Saritha Krishna, Celia A. Dodd, and Nikolay M. Filipov, “Behavioral and monoamine perturbations in adult male mice with chronic inflammation induced by repeated peripheral lipopolysaccharide administration,” Behavioural Brain Research, 2016. View at Publisher · View at Google Scholar
  • Ana West, Benjamin E. Brummel, Anthony R. Braun, Elizabeth Rhoades, and Jonathan N. Sachs, “Membrane remodeling and mechanics: Experiments and simulations of α-Synuclein,” Biochimica et Biophysica Acta (BBA) - Biomembranes, 2016. View at Publisher · View at Google Scholar
  • Zhipeng Ke, Xinzhuang Zhang, Zeyu Cao, Yue Ding, Na Li, Liang Cao, Tuanjie Wang, Chenfeng Zhang, Gang Ding, Zhenzhong Wang, Xiaojie Xu, and Wei Xiao, “Drug discovery of neurodegenerative disease through network pharmacology approach in herbs,” Biomedicine & Pharmacotherapy, vol. 78, pp. 272–279, 2016. View at Publisher · View at Google Scholar
  • Alexandra Dumitriu, Javad Golji, Adam T. Labadorf, Benbo Gao, Thomas G. Beach, Richard H. Myers, Kenneth A. Longo, and Jeanne C. Latourelle, “Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson dise,” Bmc Medical Genomics, vol. 9, 2016. View at Publisher · View at Google Scholar
  • Maykel Cruz-Monteagudo, Fernanda Borges, Cesar Paz-y-Miño, M. Natália D. S. Cordeiro, Irene Rebelo, Yunierkis Perez-Castillo, Aliuska Morales Helguera, Aminael Sánchez-Rodríguez, and Eduardo Tejera, “Efficient and biologically relevant consensus strategy for Parkinson’s disease gene prioritization,” BMC Medical Genomics, vol. 9, no. 1, 2016. View at Publisher · View at Google Scholar
  • Mikhail Saltychev, Esa Barlund, Jaana Paltamaa, Niina Katajapuu, and Katri Laimi, “Progressive resistance training in Parkinson's disease: a systematic review and meta-analysis,” Bmj Open, vol. 6, no. 1, 2016. View at Publisher · View at Google Scholar
  • Sabiha Parveen, “Comparison of self and proxy ratings for motor performance of individuals with Parkinson disease,” Brain and Cognition, vol. 103, pp. 62–69, 2016. View at Publisher · View at Google Scholar
  • Long Qian, Yi Zhang, Li Zheng, Xuemei Fu, Weiguo Liu, Yuqing Shang, Yaoyu Zhang, Yuanyuan Xu, Yijun Liu, Huaiqiu Zhu, and Jia-Hong Gao, “Frequency specific brain networks in Parkinson’s disease and comorbid depression,” Brain Imaging and Behavior, 2016. View at Publisher · View at Google Scholar
  • Jamileh Saberzadeh, Rita Arabsolghar, and Mohammad Ali Takhshid, “Alpha synuclein protein is involved in Aluminum-induced cell death and oxidative stress in PC12 cells,” Brain Research, 2016. View at Publisher · View at Google Scholar
  • Marina Picillo, Andres M. Lozano, Nancy Kou, Renato Puppi Munhoz, and Alfonso Fasano, “Programming Deep Brain Stimulation for Parkinson's disease: the Toronto Western Hospital Algorithms,” Brain Stimulation, 2016. View at Publisher · View at Google Scholar
  • Francesco Angelucci, Jacopo Piermaria, Francesca Gelfo, Jacob Shofany, Marco Tramontano, Marco Fiore, Carlo Caltagirone, and Antonella Peppe, “The effects of motor rehabilitation training on clinical symptoms and serum BDNF levels in Parkinson’s disease subjects,” Canadian Journal of Physiology and Pharmacology, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Chuang-Hsin Chiu, I-Hsun Li, Shao-Ju Weng, Yuahn-Sieh Huang, Shinn-Chih Wu, Ta-Kai Chou, Wen-Sheng Huang, Mei-Hsiu Liao, Chyng-Yann Shiue, Cheng-Yi Cheng, and Kuo-Hsing Ma, “PET Imaging of Serotonin Transporters With 4-[F-18]-ADAM in a Parkinsonian Rat Model With Porcine Neural Xenografts,” Cell Transplantation, vol. 25, no. 2, pp. 301–311, 2016. View at Publisher · View at Google Scholar
  • Indranil Basak, Ketan S. Patil, Guido Alves, Jan Petter Larsen, and Simon Geir Moller, “microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases,” Cellular And Molecular Life Sciences, vol. 73, no. 4, pp. 811–827, 2016. View at Publisher · View at Google Scholar
  • Yue-Ying Pan, Yan Deng, Sheng Xie, Zhi-Hua Wang, Yu Wang, Jie Ren, and Hui-Guo Liu, “Altered Wnt Signaling Pathway in Cognitive Impairment Caused by Chronic Intermittent Hypoxia: Focus on Glycogen Synthase Kinase-3β and β-catenin,” Chinese Medical Journal, vol. 129, no. 7, pp. 838, 2016. View at Publisher · View at Google Scholar
  • Alessandra Fanciulli, Georg Goebel, Jean Pierre Ndayisaba, Roberta Granata, Susanne Duerr, Stefano Strano, Carlo Colosimo, Werner Poewe, Francesco E. Pontieri, and Gregor K. Wenning, “Supine hypertension in Parkinson's disease and multiple system atrophy,” Clinical Autonomic Research, vol. 26, no. 2, pp. 97–105, 2016. View at Publisher · View at Google Scholar
  • Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, Hugo Morales-Briceño, Gabriel Neri-Nani, Roxanna Millán-Cepeda, and Salvador Velázquez-Osuna, “Frequency and clinical correlates of postural and striatal deformities in Parkinson’s disease,” Clinical Neurology and Neurosurgery, 2016. View at Publisher · View at Google Scholar
  • Peter A. LeWitt, Werner Poewe, Lawrence W. Elmer, Mahnaz Asgharnejad, Babak Boroojerdi, Frank Grieger, and Lars Bauer, “The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease: A Post Hoc Analysis,” Clinical Neuropharmacology, vol. 39, no. 2, pp. 88–93, 2016. View at Publisher · View at Google Scholar
  • James M. Shine, “Electrophysiological insights into freezing in Parkinson’s disease,” Clinical Neurophysiology, 2016. View at Publisher · View at Google Scholar
  • Chloe Lau Ha Chung, Shamala Thilarajah, and Dawn Tan, “Effectiveness of resistance training on muscle strength and physical function in people with Parkinson's disease: a systematic review and meta-analysi,” Clinical Rehabilitation, vol. 30, no. 1, pp. 11–23, 2016. View at Publisher · View at Google Scholar
  • P. Karunanayaka, Eun-Young Lee, Mechelle M. Lewis, Sen Suman, Paul J. Eslinger, Q.X. Yang, and Xuemei Huang, “Default Mode Network Differences between Rigidity- and Tremor-Predominant Parkinson’s Disease,” Cortex, 2016. View at Publisher · View at Google Scholar
  • Nora Toeroek, Zsofia Majlath, Ferenc Fueloep, Jozsef Toldi, and Laszlo Vecsei, “Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism,” Current Drug Metabolism, vol. 17, no. 5, pp. 412–429, 2016. View at Publisher · View at Google Scholar
  • Marius Dettmer, Amir Pourmoghaddam, Beom-Chan Lee, and Charles S. Layne, “Do Aging and Tactile Noise Stimulation Affect Responses to Support Surface Translations in Healthy Adults?,” Current Gerontology and Geriatrics Research, vol. 2016, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Marius Dettmer, Amir Pourmoghaddam, Beom-Chan Lee, and Charles S. Layne, “Associations between Tactile Sensory Threshold and Postural Performance and Effects of Healthy Aging and Subthreshold Vibrotactile Stimulation on Postural Outcomes in a Simple Dual Task,” Current Gerontology and Geriatrics Research, vol. 2016, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Juan Segura-Aguilar, Patricia Munoz, and Irmgard Paris, “Aminochrome as New Preclinical Model to Find New Pharmacological Treatment that Stop the Development of Parkinson's Disease,” Current Medicinal Chemistry, vol. 23, no. 4, pp. 346–359, 2016. View at Publisher · View at Google Scholar
  • Sen Liu, Bei Cui, Zhen-xia Dai, Peng-ke Shi, Zhao-hui Wang, and Yuan-yuan Guo, “Long Non-coding RNA HOTAIR Promotes Parkinson's Disease Induced by MPTP Through up-regulating the Expression of LRRK2,” Current Neurovascular Research, vol. 13, no. 2, pp. 115–120, 2016. View at Publisher · View at Google Scholar
  • Pawaris Wongprayoon, and Piyarat Govitrapong, “Melatonin Attenuates Methamphetamine-Induced Neurotoxicity,” Current Pharmaceutical Design, vol. 22, no. 8, pp. 1022–1032, 2016. View at Publisher · View at Google Scholar
  • Nedime Serakinci, Rasime Kalkan, and Pinar Tulay, “Double-Faced Role of Human Mesenchymal Stem Cells and their Role/Challenges in Cancer Therapy,” Current Stem Cell Research & Therapy, vol. 11, no. 4, pp. 343–351, 2016. View at Publisher · View at Google Scholar
  • Anne Yuqing Yang, Hyuck Kim, Wenji Li, and Ah-Ng Tony Kong, “Natural Compound-Derived Epigenetic Regulators Targeting Epigenetic Readers, Writers and Erasers,” Current Topics In Medicinal Chemistry, vol. 16, no. 7, pp. 697–713, 2016. View at Publisher · View at Google Scholar
  • Amit Kumar, Swati Dudhal, Abinaya T. Sundari, Mallikarjuna Sunkara, Hyder Usman, Anurag Varshney, and Asok Mukhopadhyay, “Dopaminergic-primed fetal liver mesenchymal stromal-like cells can reverse parkinsonian symptoms in 6-hydroxydopamine-lesioned mice,” Cytotherapy, vol. 18, no. 3, pp. 307–319, 2016. View at Publisher · View at Google Scholar
  • Yasir Hasan Siddique, Wasi Khan, Ambreen Fatima, Smita Jyoti, Saba Khanam, Falaq Naz, Rahul, Fahad Ali, Braj Raj Singh, and Alim Hussain Naqvi, “Effect of bromocriptine alginate nanocomposite (BANC) on a transgenic Drosophila model of Parkinson's disease,” Disease Models & Mechanisms, vol. 9, no. 1, pp. 63–68, 2016. View at Publisher · View at Google Scholar
  • Berrak Ugur, Kuchuan Chen, and Hugo J. Bellen, “Drosophila tools and assays for the study of human diseases,” Disease Models & Mechanisms, vol. 9, no. 3, pp. 235–244, 2016. View at Publisher · View at Google Scholar
  • Yasir Hasan Siddique, Falaq Naz, Smita Jyoti, Fahad Ali, Ambreen Fatima, Rahul, and Saba Khanam, “Protective effect of Geraniol on the transgenic Drosophila model of Parkinson’s disease,” Environmental Toxicology and Pharmacology, 2016. View at Publisher · View at Google Scholar
  • M. Bang Henriksen, E. L. Johnsen, N. Sunde, A. Vase, M. C. Gjelstrup, and K. Ostergaard, “Surviving 10 years with deep brain stimulation for Parkinson's disease - a follow-up of 79 patients,” European Journal Of Neurology, vol. 23, no. 1, pp. 53–61, 2016. View at Publisher · View at Google Scholar
  • Eimear O’Connell, and Marie Guidon, “Fear of falling and dual-task performance in people with Parkinson’s disease,” European Journal of Physiotherapy, pp. 1–6, 2016. View at Publisher · View at Google Scholar
  • S. Y. Schaefer, and C. R. Hengge, “Testing the concurrent validity of a naturalistic upper extremity reaching task,” Experimental Brain Research, vol. 234, no. 1, pp. 229–240, 2016. View at Publisher · View at Google Scholar
  • Félix Javier Jiménez-Jiménez, Hortensia Alonso-Navarro, Elena García-Martín, and José A. G. Agúndez, “Advances in understanding genomic markers and pharmacogenetics of Parkinson’s disease,” Expert Opinion on Drug Metabolism & Toxicology, pp. 1–16, 2016. View at Publisher · View at Google Scholar
  • Santiago Perez-Lloret, and Olivier Rascol, “The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease,” Expert Review Of Neurotherapeutics, vol. 16, no. 3, pp. 245–258, 2016. View at Publisher · View at Google Scholar
  • Song-Hee Kim, Yong-Yea Park, Young-Suk Yoo, and Hyeseong Cho, “Self-clearance mechanism of mitochondrial E3 ligase MARCH5 contributes to mitochondria quality control,” Febs Journal, vol. 283, no. 2, pp. 294–304, 2016. View at Publisher · View at Google Scholar
  • Kaige Ji, Yudan Zhao, Tianhong Yu, Zhuoyi Wang, Hao Gong, Xin Yang, Yang Liu, and Kun Huang, “Inhibition effects of tanshinone on the aggregation of α-synuclein,” Food Funct., vol. 7, no. 1, pp. 409–416, 2016. View at Publisher · View at Google Scholar
  • Noelia Calvo, Adolfo M. García, Laura Manoiloff, and Agustín Ibáñez, “Bilingualism and Cognitive Reserve: A Critical Overview and a Plea for Methodological Innovations,” Frontiers in Aging Neuroscience, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Morad Elshehabi, Katrin S. Maier, Sandra E. Hasmann, Susanne Nussbaum, Heinz Herbst, Tanja Heger, Daniela Berg, Markus A. Hobert, and Walter Maetzler, “Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson’s Disease during Single and Dual Tasking,” Frontiers in Aging Neuroscience, vol. 8, 2016. View at Publisher · View at Google Scholar
  • Juhyun Song, and Jongpil Kim, “Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson’s Disease,” Frontiers in Aging Neuroscience, vol. 8, 2016. View at Publisher · View at Google Scholar
  • Isobel T. French, and Kalai A. Muthusamy, “A Review of Sleep and Its Disorders in Patients with Parkinson's Disease in Relation to Various Brain Structures,” Frontiers in Aging Neuroscience, vol. 8, 2016. View at Publisher · View at Google Scholar
  • Ahmed M. Fathalla, Amira M. Soliman, Mohamed H. Ali, and Ahmed A. Moustafa, “Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism,” Frontiers in Behavioral Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Celeste Leung, and Zhengping Jia, “Mouse Genetic Models of Human Brain Disorders,” Frontiers in Genetics, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Anna A. Bukowska, Piotr Krezalek, Elzbieta Mirek, Przemyslaw Bujas, and Anna Marchewka, “Neurologic Music Therapy Training for Mobility and Stability Rehabilitation with Parkinson's Disease - A Pilot Study,” Frontiers In Human Neuroscience, vol. 9, 2016. View at Publisher · View at Google Scholar
  • Petra Zemankova, Ovidiu Lungu, and Martin Bares, “Psychosocial Modulators of Motor Learning in Parkinson’s Disease,” Frontiers in Human Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Rafael Elias Marques, Pedro Elias Marques, Rodrigo Guabiraba, and Mauro Martins Teixeira, “Exploring the Homeostatic and Sensory Roles of the Immune System,” Frontiers in Immunology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Donatus Cyron, “Mental Side Effects of Deep Brain Stimulation (DBS) for Movement Disorders: The Futility of Denial,” Frontiers in Integrative Neuroscience, vol. 10, 2016. View at Publisher · View at Google Scholar
  • Alexander A. Nevue, Cameron J. Elde, David J. Perkel, and Christine V. Portfors, “Dopaminergic Input to the Inferior Colliculus in Mice,” Frontiers in Neuroanatomy, vol. 9, 2016. View at Publisher · View at Google Scholar
  • Glenna Batson, Christina E. Hugenschmidt, and Christina T. Soriano, “Verbal Auditory Cueing of Improvisational Dance: A Proposed Method for Training Agency in Parkinson’s Disease,” Frontiers in Neurology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Nir Giladi, Anat Mirelman, Avner Thaler, and Avi Orr-Urtreger, “A Personalized Approach to Parkinson’s Disease Patients Based on Founder Mutation Analysis,” Frontiers in Neurology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • Daniel M. Johnstone, Cecile Moro, Jonathan Stone, Alim-Louis Benabid, and John Mitrofanis, “Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease,” Frontiers In Neuroscience, vol. 9, 2016. View at Publisher · View at Google Scholar
  • Daniel M. Johnstone, Cécile Moro, Jonathan Stone, Alim-Louis Benabid, and John Mitrofanis, “Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease,” Frontiers in Neuroscience, vol. 9, 2016. View at Publisher · View at Google Scholar
  • Douglas G. Walker, Lih-Fen Lue, Geidy Serrano, Charles H. Adler, John N. Caviness, Lucia I. Sue, and Thomas G. Beach, “Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases,” Frontiers in Neuroscience, vol. 9, 2016. View at Publisher · View at Google Scholar
  • Carola Salvi, and Edward M. Bowden, “Looking for Creativity: Where Do We Look When We Look for New Ideas?,” Frontiers in Psychology, vol. 7, 2016. View at Publisher · View at Google Scholar
  • A. Bengevoord, G. Vervoort, J. Spildooren, E. Heremans, W. Vandenberghe, B. R. Bloem, and A. Nieuwboer, “Center of mass trajectories during turning in patients with Parkinson's disease with and without freezing of gait,” Gait & Posture, vol. 43, pp. 54–59, 2016. View at Publisher · View at Google Scholar
  • Xiaoliu Dong, Tiejun Liu, Shijun Xu, Lixia Zhu, Panpan Zhang, Aibin Cheng, and Qingqiang Qian, “The relevance of ABCA1 R219K polymorphisms and serum ABCA1 protein concentration to Parkinson's disease pathogenesis and classification: a case-contro,” Genes & Genomics, vol. 38, no. 3, pp. 243–250, 2016. View at Publisher · View at Google Scholar
  • Evelyn Hearne, Jean-Paul Cornelius Grund, Marie Claire Van Hout, and Jim McVeigh, “A scoping review of home-produced heroin and amphetamine-type stimulant substitutes: implications for prevention, treatment, and policy,” Harm Reduction Journal, vol. 13, no. 1, 2016. View at Publisher · View at Google Scholar
  • Nicholas J. Lavalley, Sunny R. Slone, Huiping Ding, Andrew B. West, and Talene A. Yacoubian, “14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening,” Human Molecular Genetics, vol. 25, no. 1, pp. 109–122, 2016. View at Publisher · View at Google Scholar
  • Jingnan Liu, Tianxia Li, Joseph M. Thomas, Zhong Pei, Haibing Jiang, Simone Engelender, Christopher A. Ross, and Wanli W. Smith, “Synphilin-1 attenuates mutant LRRK2-induced neurodegeneration in Parkinson's disease models,” Human Molecular Genetics, vol. 25, no. 4, pp. 672–680, 2016. View at Publisher · View at Google Scholar
  • Florian Kolbl, Gilles N'Kaoua, Frederic Naudet, Florent Berthier, Emilie Faggiani, Sylvie Renaud, Abdelhamid Benazzouz, and Noelle Lewis, “An Embedded Deep Brain Stimulator for Biphasic Chronic Experiments in Freely Moving Rodents,” IEEE Transactions on Biomedical Circuits and Systems, vol. 10, no. 1, pp. 72–84, 2016. View at Publisher · View at Google Scholar
  • Harris A. Eyre, Ascia Eskin, Stanley F. Nelson, Natalie M. St Cyr, Prabha Siddarth, Bernhard T. Baune, and Helen Lavretsky, “Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study,” International Journal Of Geriatric Psychiatry, vol. 31, no. 5, pp. 510–517, 2016. View at Publisher · View at Google Scholar
  • Angelica Beatriz Ortiz de Gortari, and Mark D. Griffiths, “Prevalence and Characteristics of Game Transfer Phenomena: A Descriptive Survey Study,” International Journal of Human-Computer Interaction, 2016. View at Publisher · View at Google Scholar
  • Jin Choi, Gunhyuk Park, Hyo Kim, Dal-Seok Oh, Hocheol Kim, and Myung Oh, “In Vitro and in Vivo Neuroprotective Effects of Walnut (Juglandis Semen) in Models of Parkinson’s Disease,” International Journal of Molecular Sciences, vol. 17, no. 1, pp. 108, 2016. View at Publisher · View at Google Scholar
  • Laura Vella, Andrew Hill, and Lesley Cheng, “Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer’s and Parkinson’s Disease,” International Journal of Molecular Sciences, vol. 17, no. 2, pp. 173, 2016. View at Publisher · View at Google Scholar
  • Aslina Pahrudin Arrozi, Wan Zurinah Wan Ngah, Yasmin Anum Mohd Yusof, Mohd Hanafi Ahmad Damanhuri, and Suzana Makpol, “Antioxidant modulation in restoring mitochondrial function in neurodegeneration,” International Journal of Neuroscience, pp. 1–18, 2016. View at Publisher · View at Google Scholar
  • Filsy Samuel, William P. Flavin, Sobia Iqbal, Consiglia Pacelli, Sri Dushyaanthan Sri Renganathan, Louis-Eric Trudeau, Edward M. Campbell, Paul E. Fraser, and Anurag Tandon, “Effects of Serine 129 Phosphorylation on alpha-Synuclein Aggregation, Membrane Association, and Internalization,” Journal Of Biological Chemistry, vol. 291, no. 9, pp. 4374–4385, 2016. View at Publisher · View at Google Scholar
  • Naveed Ahmad Fazili, Imtiyaz Ahmad Bhat, Waseem Feeroze Bhat, and Aabgeena Naeem, “Anti-fibrillation propensity of a flavonoid baicalein against the fibrils of hen egg white lysozyme: potential therapeutics for lysozyme amyloidosis,” Journal of Biomolecular Structure and Dynamics, pp. 1–13, 2016. View at Publisher · View at Google Scholar
  • Marian L. Dale, Martina Mancini, Carolin Curtze, Fay B. Horak, and Brett W. Fling, “Freezing of gait associated with a corpus callosum lesion,” Journal of Clinical Movement Disorders, vol. 3, no. 1, 2016. View at Publisher · View at Google Scholar
  • Jack K. Garlovsky, Paul G. Overton, and Jane Simpson, “Psychological Predictors of Anxiety and Depression in Parkinson's Disease: A Systematic Review,” Journal of Clinical Psychology, 2016. View at Publisher · View at Google Scholar
  • Linda Clare, Christopher J. Whitaker, Anthony Martyr, Pamela A. Martin-Forbes, Alexandra J.M. Bastable, Kirstie L. Pye, Catherine Quinn, Enlli M. Thomas, Virginia C. Mueller Gathercole, and John V. Hindle, “Executive control in older Welsh monolinguals and bilinguals,” Journal of Cognitive Psychology, pp. 1–15, 2016. View at Publisher · View at Google Scholar
  • Yuko Yasui, and Tsung-Ping Su, “Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine,” Journal of Drug and Alcohol Research, vol. 5, pp. 1–15, 2016. View at Publisher · View at Google Scholar
  • Paola Castrogiovanni, Francesca Trovato, Marta Szychlinska, Carla Loreto, Salvatore Giunta, Soraya Scuderi, Roberta Passanisi, Federica Fidone, Paolo Fagone, Rosa Imbesi, Ferdinando Nicoletti, and Sergio Castorina, “Effects of Synthetic Anti-Inflammatory Sterol in CB3V-Induced Myocarditis: A Morphological Study on Heart Muscle Tissue,” Journal of Functional Morphology and Kinesiology, vol. 1, no. 1, pp. 69–89, 2016. View at Publisher · View at Google Scholar
  • Anyamanee Yingyongyudha, Vitoon Saengsirisuwan, Wanvisa Panichaporn, and Rumpa Boonsinsukh, “The Mini-Balance Evaluation Systems Test (Mini-BESTest) Demonstrates Higher Accuracy in Identifying Older Adult Participants With History of Falls Tha,” Journal Of Geriatric Physical Therapy, vol. 39, no. 2, pp. 64–70, 2016. View at Publisher · View at Google Scholar
  • Hyung-Eun Park, Joong-Seok Kim, Yoon-Sang Oh, In-Seok Park, Jeong-Wook Park, In-Uk Song, and Kwang-Soo Lee, “Autonomic Nervous System Dysfunction in Patients With Parkinson Disease Having Depression,” Journal Of Geriatric Psychiatry And Neurology, vol. 29, no. 1, pp. 11–17, 2016. View at Publisher · View at Google Scholar
  • Ângela Fernandes, Andreia S. P. Sousa, Nuno Rocha, and João Manuel R. S. Tavares, “Parkinson's Disease and Cognitive-Motor Dual-Task: Is Motor Prioritization Possible in the Early Stages of the Disease?,” Journal of Motor Behavior, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Edna Gruenblatt, and Peter Riederer, “Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease,” Journal Of Neural Transmission, vol. 123, no. 2, pp. 83–90, 2016. View at Publisher · View at Google Scholar
  • Pamela Lopert, and Manisha Patel, “Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease,” Journal Of Neural Transmission, vol. 123, no. 2, pp. 113–123, 2016. View at Publisher · View at Google Scholar
  • Johannes Levin, Alkomiet Hasan, and Guenter U. Hoeglinger, “Psychosis in Parkinson's disease: identification, prevention and treatment,” Journal Of Neural Transmission, vol. 123, no. 1, pp. 45–50, 2016. View at Publisher · View at Google Scholar
  • Ilona Csoti, Wolfgang H. Jost, and Heinz Reichmann, “Parkinson's disease between internal medicine and neurology,” Journal Of Neural Transmission, vol. 123, no. 1, pp. 3–17, 2016. View at Publisher · View at Google Scholar
  • Ruxandra Julia Vorovenci, Roberta Biundo, and Angelo Antonini, “Therapy-resistant symptoms in Parkinson's disease,” Journal Of Neural Transmission, vol. 123, no. 1, pp. 19–30, 2016. View at Publisher · View at Google Scholar
  • Jan Rusz, Tereza Tykalová, Jiří Klempíř, Roman Čmejla, and Evžen Růžička, “Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: longitudinal follow-up study on previously untreated patients,” Journal of Neural Transmission, 2016. View at Publisher · View at Google Scholar
  • Davor Ivankovic, Kai-Yin Chau, Anthony H. V. Schapira, and Matthew E. Gegg, “Mitochondrial and lysosomal biogenesis are activated following PINK1/parkin-mediated mitophagy,” Journal Of Neurochemistry, vol. 136, no. 2, pp. 388–402, 2016. View at Publisher · View at Google Scholar
  • Josien de Bie, Jade Guest, Gilles J. Guillemin, and Ross Grant, “Central kynurenine pathway shift with age in women,” Journal Of Neurochemistry, vol. 136, no. 5, pp. 995–1003, 2016. View at Publisher · View at Google Scholar